Literature DB >> 8432473

Antineutrophil antibody: a test for autoimmune primary sclerosing cholangitis in childhood?

S K Lo1, R W Chapman, P Cheeseman, C P Charlton, J A Walker-Smith, G Mieli-Vergani, K A Fleming.   

Abstract

The detection of an antineutrophil antibody which is highly sensitive and specific for adult primary sclerosing cholangitis using indirect immunoalkaline phosphatase has been previously described. In this study, the diagnostic potential of this method in childhood primary sclerosing cholangitis is described. A range of 72 blinded children's sera (36 boys), aged six months to 21 years (10 primary sclerosing cholangitis, eight autoimmune chronic active hepatitis, 10 alpha-1 antitrypsin deficiency, 12 extrahepatic bile duct atresia, 11 ulcerative colitis and 21 normal subjects) was assayed. Eight of the 10 primary sclerosing cholangitis patients were correctly identified. Three patients with chronic active hepatitis also showed the characteristic primary sclerosing cholangitis pattern of staining. No ulcerative colitis patients or any other patients showed this pattern of staining. All normal subjects were negative. As in adult primary sclerosing cholangitis, there is a specific antineutrophil antibody in childhood primary sclerosing cholangitis and this provides further evidence towards an autoimmune aetiology of this condition. The test may have diagnostic potential.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432473      PMCID: PMC1373970          DOI: 10.1136/gut.34.2.199

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.

Authors:  R H Duerr; S R Targan; C J Landers; N F LaRusso; K L Lindsay; R H Wiesner; F Shanahan
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

2.  The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

Authors:  T L Fong; A M Di Bisceglie; J G Waggoner; S M Banks; J H Hoofnagle
Journal:  Hepatology       Date:  1991-07       Impact factor: 17.425

3.  Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.

Authors:  J A Snook; R W Chapman; K Fleming; D P Jewell
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

4.  A case of primary sclerosing cholangitis in childhood.

Authors:  W Spivak; R J Grand; A Eraklis
Journal:  Gastroenterology       Date:  1982-01       Impact factor: 22.682

5.  Sclerosing cholangitis in childhood.

Authors:  S L Werlin; M Glicklich; J Jona; R J Starshak
Journal:  J Pediatr       Date:  1980-03       Impact factor: 4.406

6.  Clinicopathologic features of the syndrome of primary sclerosing cholangitis.

Authors:  R H Wiesner; N F LaRusso
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

7.  Sclerosing cholangitis associated with inflammatory bowel disease.

Authors:  D Freese; J S Latimer; S Gilberstadt; W Kane; H L Sharp
Journal:  Clin Pediatr (Phila)       Date:  1982-01       Impact factor: 1.168

8.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.

Authors:  R W Chapman; B A Arborgh; J M Rhodes; J A Summerfield; R Dick; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

9.  Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.

Authors:  S K Lo; K A Fleming; R W Chapman
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

10.  Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood.

Authors:  G Mieli-Vergani; A Lobo-Yeo; B M McFarlane; I G McFarlane; A P Mowat; D Vergani
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

View more
  3 in total

Review 1.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

2.  Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.

Authors:  D S Bansi; K A Fleming; R W Chapman
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

3.  Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.

Authors:  A Vidrich; J Lee; E James; L Cobb; S Targan
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.